Blood Transfusion Diagnostics Market
Blood Transfusion Diagnostics Market By Product Type (Instruments, Kits & Reagents), By Application (Blood Grouping, Molecular Disease Screening), By End-user & By Region - Global Market Insights 2022-2032
Analysis of Blood Transfusion Diagnostics Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Table of Content
1. Preface 1.1. Market Definition and Scope 1.2. Market Segmentation 1.3. Key Research Objectives 1.4. Research Highlights 2. Assumptions and Research Methodology 3. Executive Summary: Global Market 4. Market Overview 4.1. Introduction 4.1.1. Product Type Definition 4.1.2. Industry Evolution / Developments 4.2. Overview 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.4. Global Market Analysis and Forecasts, 2022-2032 4.4.1. Market Revenue Projections (US$ Mn) 4.5. Porter’s Five Force Analysis 5. Spend for Plasma Testing For Infectious Diseases (US$ Mn), by Plasma Fractionation Companies, 2022 6. Global Market Analysis and Forecasts, by Product Type 6.1. Introduction & Definition 6.2. Key Findings / Developments 6.3. Market Value Forecast, by Product Type, 2022-2032 6.3.1. Instruments 6.3.2. Kits & Reagents 6.4. Market Attractiveness, by Product Type 7. Global Market Analysis and Forecasts, by Application 7.1. Introduction & Definition 7.2. Key Findings / Developments 7.3. Market Value Forecast, by Application, 2022-2032 7.3.1. Blood Grouping 7.3.2. Disease Screening 7.3.2.1. Serological Disease Screening 7.3.2.2. Molecular Disease Screening 7.4. Market Attractiveness, by Application 8. Global Market Analysis and Forecasts, by End-user 8.1. Introduction & Definition 8.2. Key Findings / Developments 8.3. Market Value Forecast, by End-user, 2022-2032 8.3.1. Hospitals 8.3.2. Blood Banks 8.3.3. Diagnostic Laboratories 8.3.4. Plasma Fractionation Companies 8.3.5. Others 8.4. Market Attractiveness, by End-user 9. Global Market Analysis and Forecasts, by Region 9.1. Key Findings 9.2. Market Value Forecast, by Region 9.2.1. North America 9.2.2. Europe 9.2.3. Asia Pacific 9.2.4. Latin America 9.2.5. Middle East & Africa 9.3. Market Attractiveness, by Region 10. North America Market Analysis and Forecast 10.1. Introduction 10.1.1. Key Findings 10.2. Market Value Forecast, by Product Type, 2022-2032 10.2.1. Instruments 10.2.2. Kits & Reagents 10.3. Market Value Forecast, by Application, 2022-2032 10.3.1. Blood Grouping 10.3.2. Disease Screening 10.3.2.1. Serological Disease Screening 10.3.2.2. Molecular Disease Screening 10.4. Market Value Forecast, by End-user, 2022-2032 10.4.1. Hospitals 10.4.2. Blood Banks 10.4.3. Diagnostic Laboratories 10.4.4. Plasma Fractionation Companies 10.4.5. Others 10.5. Market Value Forecast, by Country, 2022-2032 10.5.1. U.S. 10.5.2. Canada 10.6. Market Attractiveness Analysis 10.6.1. By Product Type 10.6.2. By Application 10.6.3. By End-user 10.6.4. By Country 11. Europe Market Analysis and Forecast 11.1. Introduction 11.1.1. Key Findings 11.2. Market Value Forecast, by Product Type, 2022-2032 11.2.1. Instruments 11.2.2. Kits & Reagents 11.3. Market Value Forecast, by Application, 2022-2032 11.3.1. Blood Grouping 11.3.2. Disease Screening 11.3.2.1. Serological Disease Screening 11.3.2.2. Molecular Disease Screening 11.4. Market Value Forecast, by End-user, 2022-2032 11.4.1. Hospitals 11.4.2. Blood Banks 11.4.3. Diagnostic Laboratories 11.4.4. Plasma Fractionation Companies 11.4.5. Others 11.5. Market Value Forecast, by Country/Sub-region, 2022-2032 11.5.1. Germany 11.5.2. U.K. 11.5.3. France 11.5.4. Spain 11.5.5. Italy 11.5.6. Rest of Europe 11.6. Market Attractiveness Analysis 11.6.1. By Product Type 11.6.2. By Application 11.6.3. By End-user 11.6.4. By Country/Sub-region 12. Asia Pacific Market Analysis and Forecast 12.1. Introduction 12.1.1. Key Findings 12.2. Market Value Forecast, by Product Type, 2022-2032 12.2.1. Instruments 12.2.2. Kits & Reagents 12.3. Market Value Forecast, by Application, 2022-2032 12.3.1. Blood Grouping 12.3.2. Disease Screening 12.3.2.1. Serological Disease Screening 12.3.2.2. Molecular Disease Screening 12.4. Market Value Forecast, by End-user, 2022-2032 12.4.1. Hospitals 12.4.2. Blood Banks 12.4.3. Diagnostic Laboratories 12.4.4. Plasma Fractionation Companies 12.4.5. Others 12.5. Market Value Forecast, by Country/Sub-region, 2022-2032 12.5.1. China 12.5.2. Japan 12.5.3. India 12.5.4. Rest of Asia Pacific 12.6. Market Attractiveness Analysis 12.6.1. By Product Type 12.6.2. By Application 12.6.3. By End-user 12.6.4. By Country/Sub-region 13. Latin America Market Analysis and Forecast 13.1. Introduction 13.1.1. Key Findings 13.2. Market Value Forecast, by Product Type, 2022-2032 13.2.1. Instruments 13.2.2. Kits & Reagents 13.3. Market Value Forecast, by Application, 2022-2032 13.3.1. Blood Grouping 13.3.2. Disease Screening 13.3.2.1. Serological Disease Screening 13.3.2.2. Molecular Disease Screening 13.4. Market Value Forecast, by End-user, 2022-2032 13.4.1. Hospitals 13.4.2. Blood Banks 13.4.3. Diagnostic Laboratories 13.4.4. Plasma Fractionation Companies 13.4.5. Others 13.5. Market Value Forecast, by Country/Sub-region, 2022-2032 13.5.1. Brazil 13.5.2. Mexico 13.5.3. Rest of Latin America 13.6. Market Attractiveness Analysis 13.6.1. By Product Type 13.6.2. By Application 13.6.3. By End-user 13.6.4. By Country/Sub-region 14. Middle East & Africa Market Analysis and Forecast 14.1. Introduction 14.1.1. Key Findings 14.2. Market Value Forecast, by Product Type, 2022-2032 14.2.1. Instruments 14.2.2. Kits & Reagents 14.3. Market Value Forecast, by Application, 2022-2032 14.3.1. Blood Grouping 14.3.2. Disease Screening 14.3.2.1. Serological Disease Screening 14.3.2.2. Molecular Disease Screening 14.4. Market Value Forecast, by End-user, 2022-2032 14.4.1. Hospitals 14.4.2. Blood Banks 14.4.3. Diagnostic Laboratories 14.4.4. Plasma Fractionation Companies 14.4.5. Others 14.5. Market Value Forecast, by Country/Sub-region, 2022-2032 14.5.1. Saudi Arabia 14.5.2. South Africa 14.5.3. Rest of Middle East & Africa 14.6. Market Attractiveness Analysis 14.6.1. By Product Type 14.6.2. By Application 14.6.3. By End-user 14.6.4. By Country/Sub-region 15. Company Profiles 15.1. Market Player - Competition Matrix (By Tier and Size of companies) 15.2. Market Share Analysis, by Company, 2020 (estimated) 15.3. Company Profiles 15.3.1. Grifols S.A. 15.3.1.1. Company Details 15.3.1.2. Business Overview 15.3.1.3. Financial Overview 15.3.1.4. Strategic Overview 15.3.1.5. SWOT Analysis 15.3.2. Immucor, Inc. 15.3.2.1. Company Details 15.3.2.2. Business Overview 15.3.2.3. Financial Overview 15.3.2.4. Strategic Overview 15.3.2.5. SWOT Analysis 15.3.3. Ortho Clinical Diagnostics 15.3.3.1. Company Details 15.3.3.2. Business Overview 15.3.3.3. Financial Overview 15.3.3.4. Strategic Overview 15.3.3.5. SWOT Analysis 15.3.4. Abbott 15.3.4.1. Company Details 15.3.4.2. Business Overview 15.3.4.3. Financial Overview 15.3.4.4. Strategic Overview 15.3.4.5. SWOT Analysis 15.3.5. Bio-Rad Laboratories, Inc. 15.3.5.1. Company Details 15.3.5.2. Business Overview 15.3.5.3. Financial Overview 15.3.5.4. Strategic Overview 15.3.5.5. SWOT Analysis 15.3.6. F. Hoffman-La Roche Ltd. 15.3.6.1. Company Details 15.3.6.2. Business Overview 15.3.6.3. Financial Overview 15.3.6.4. Strategic Overview 15.3.6.5. SWOT Analysis 15.3.7. QUOTIENT LIMITED 15.3.7.1. Company Details 15.3.7.2. Business Overview 15.3.7.3. Financial Overview 15.3.7.4. Strategic Overview 15.3.7.5. SWOT Analysis 15.3.8. BAG Healthcare GmBH 15.3.8.1. Company Details 15.3.8.2. Business Overview 15.3.8.3. Financial Overview 15.3.8.4. Strategic Overview 15.3.8.5. SWOT Analysis 15.3.9. DiaSorin S.p.A. 15.3.9.1. Company Details 15.3.9.2. Business Overview 15.3.9.3. Financial Overview 15.3.9.4. Strategic Overview 15.3.9.5. SWOT Analysis 15.3.10. Hologic, Inc. 15.3.10.1. Company Details 15.3.10.2. Business Overview 15.3.10.3. Financial Overview 15.3.10.4. Strategic Overview 15.3.10.5. SWOT Analysis
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Revenue (US$ Mn) Forecast, by Product Type, 2022-2032
Table 02: Global Market Revenue (US$ Mn) Forecast, by Application, 2022-2032
Table 03: Global Market Revenue (US$ Mn) Forecast, by Disease Screening, 2022-2032
Table 04: Global Market Revenue (US$ Mn) Forecast, by End-user, 2022-2032
Table 05: Global Market Revenue (US$ Mn) Forecast, by Region, 2022-2032
Table 06: North America Market Revenue (US$ Mn) Forecast, by Country, 2022-2032
Table 07: North America Market Revenue (US$ Mn) Forecast, by Product Type, 2022-2032
Table 08: North America Market Revenue (US$ Mn) Forecast, by Application, 2022-2032
Table 09: North America Market Revenue (US$ Mn) Forecast, by Disease Screening, 2022-2032
Table 10: North America Market Revenue (US$ Mn) Forecast, by End User, 2022-2032
Table 11: Europe Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2022-2032
Table 12: Europe Market Revenue (US$ Mn) Forecast, by Product Type, 2022-2032
Table 13: Europe Market Revenue (US$ Mn) Forecast, by Application, 2022-2032
Table 14: Europe Market Revenue (US$ Mn) Forecast, by Disease Screening, 2022-2032
Table 15: Europe Market Revenue (US$ Mn) Forecast, by End-user, 2022-2032
Table 16: Asia Pacific Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2022-2032
Table 17: Asia Pacific Market Revenue (US$ Mn) Forecast, by Product Type, 2022-2032
Table 18: Asia Pacific Market Revenue (US$ Mn) Forecast, by Application, 2022-2032
Table 19: Asia Pacific Market Revenue (US$ Mn) Forecast, by Disease Screening, 2022-2032
Table 20: Asia Pacific Market Revenue (US$ Mn) Forecast, by End User, 2022-2032
Table 21: Latin America Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2022-2032
Table 22: Latin America Market Revenue (US$ Mn) Forecast, by Product Type, 2022-2032
Table 23: Latin America Market Revenue (US$ Mn) Forecast, by Application, 2022-2032
Table 24: Latin America Market Revenue (US$ Mn) Forecast, by Disease Screening, 2022-2032
Table 25: Latin America Market Revenue (US$ Mn) Forecast, by End-user, 2022-2032
Table 26: Middle East & Africa Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2022-2032
Table 27: Middle East & Africa Market Revenue (US$ Mn) Forecast, by Product Type, 2022-2032
Table 28: Middle East & Africa Market Revenue (US$ Mn) Forecast, by Application, 2022-2032
Table 29: Middle East & Africa Market Revenue (US$ Mn) Forecast, by Disease Screening, 2022-2032
Table 30: Middle East & Africa Market Revenue (US$ Mn) Forecast, by End-user, 2022-2032
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Size (US$ Mn) Forecast, 2022-2032
Figure 02: Global Market Value Share, by Region (2018)
Figure 04: Global Market Value Share, by Application (2018)
Figure 03: Global Market Value Share, by Product Type (2018)
Figure 05: Global Market Value Share, by End-user (2018)
Figure 06: Global Market Value Share, by Product Type, 2022 and 2032
Figure 07: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Instruments, 2022-2032
Figure 08: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Kits & Reagents,
Figure 09: Global Market Attractiveness, by Product Type, 2022-2032
Figure 10: Global Market Value Share, by Application, 2022 and 2032
Figure 11: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Blood Grouping, 2022-2032
Figure 12: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Disease Screening,
Figure 13: Global Market Attractiveness, by Application, 2022-2032
Figure 14: Global Market Value Share, by End-user, 2022 and 2032
Figure 15: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospitals, 2022-2032
Figure 16: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Blood Banks,
Figure 17: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Diagnostic Laboratories, 2022-2032
Figure 18: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Plasma Fractionation Companies, 2022-2032
Figure 19: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2022-2032
Figure 20: Global Market Attractiveness, by End-user, 2022-2032
Figure 21: Global Market Value Share, by Region, 2022 and 2032
Figure 22: Global Market Attractiveness, by Region, 2022-2032
Figure 23: North America Market Value Share, by Country, 2022 and 2032
Figure 24: North America Market Attractiveness, by Country, 2022-2032
Figure 25: North America Market Value Share, by Product Type, 2022 and 2032
Figure 26: North America Market Attractiveness, by Product Type, 2022-2032
Figure 27: North America Market Value Share, by Application, 2022 and 2032
Figure 28: North America Market Attractiveness, by Application, 2022-2032
Figure 29: North America Market Value Share, by End-user, 2022 and 2032
Figure 30: North America Market Attractiveness, by End-user, 2022-2032
Figure 31: Europe Market Value Share, by Country/Sub-region, 2022 and 2032
Figure 32: Europe Market Attractiveness, by Country/Sub-region, 2022-2032
Figure 33: Europe Market Value Share, by Product Type, 2022 and 2032
Figure 34: Europe Market Attractiveness, by Product Type, 2022-2032
Figure 35: Europe Market Value Share, by Application, 2022 and 2032
Figure 36: Europe Market Attractiveness, by Application, 2022-2032
Figure 37: Europe Market Value Share, by End-user, 2022 and 2032
Figure 38: Europe Market Attractiveness, by End-user, 2022-2032
Figure 39: Asia Pacific Market Value Share, by Country/Sub-region, 2022 and 2032
Figure 40: Asia Pacific Market Attractiveness, by Country/Sub-region, 2022-2032
Figure 41: Asia Pacific Market Value Share, by Product Type, 2022 and 2032
Figure 42: Asia Pacific Market Attractiveness, by Product Type, 2022-2032
Figure 43: Asia Pacific Market Value Share, by Application, 2022 and 2032
Figure 44: Asia Pacific Market Attractiveness, by Application, 2022-2032
Figure 45: Asia Pacific Market Value Share, by End-user, 2022 and 2032
Figure 46: Asia Pacific Market Attractiveness, by End-user, 2022-2032
Figure 47: Latin America Market Value Share, by Country/Sub-region, 2020 and 2025
Figure 48: Latin America Market Attractiveness, by Country/Sub-Region, 2022-2032
Figure 49: Latin America Market Value Share, by Product Type, 2022 and 2032
Figure 50: Latin America Market Attractiveness, by Product Type, 2022-2032
Figure 51: Latin America Market Value Share, by Application, 2022 and 2032
Figure 52: Latin America Market Attractiveness, by Application, 2022-2032
Figure 53: Latin America Market Value Share, by End-user, 2022 and 2032
Figure 54: Latin America Market Attractiveness, by End-user, 2022-2032
Figure 55: Middle East & Africa Market Value Share, by Country/Sub-Region, 2022 and 2032
Figure 56: Middle East & Africa Market Attractiveness, by Country/Sub-region, 2022-2032
Figure 57: Middle East & Africa Market Value Share, by Product Type, 2022 and 2032
Figure 58: Middle East & Africa Market Attractiveness, by Product Type, 2022-2032
Figure 59: Middle East & Africa Market Value Share, by Application, 2022 and 2032
Figure 60: Middle East & Africa Market Attractiveness, by Application, 2022-2032
Figure 61: Middle East & Africa Market Value Share, by End-user, 2022 and 2032
Figure 62: Middle East & Africa Market Attractiveness, by End-user, 2022-2032
Figure 63: Global Market Share (%) & Market Share Range (%), by Company, 2020 (Estimated)
Figure 64: Grifols S.A. Breakdown of Net Sales, by Business Segment, 2020
Figure 65: Grifols S.A. Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2021
Figure 66: DiaSorin S.p.A. Breakdown of Net Sales, by Region, 2020
Figure 67: DiaSorin S.p.A. Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2021
Figure 68: Immucor, Inc., Breakdown of Net Sales, by Product Group, 2021
Figure 69: Immucor, Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2021
Figure 70: Abbott Breakdown of Revenue (US$ Mn), by Region, 2021
Figure 71: Abbott Revenue (US$ Bn) and Y-o-Y Growth (%), 2017-2021
Figure 72: Bio-Rad Laboratories, Inc., Breakdown of Net Sales, by Region, 2021
Figure 73: Bio-Rad Laboratories, Inc., Revenue (US$ Bn) and Y-o-Y Growth (%), 2017-2021
Figure 74: Hologic, Inc., Breakdown of Net Sales, by Region, 2021
Figure 75: Hologic, Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2021
Figure 76: QUOTIENT LIMITED, Breakdown of Net Sales, by Product Group, 2021
Figure 77: QUOTIENT LIMITED, Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2021
Figure 78: F. Hoffmann-La Roche Ltd., Breakdown of Net Sales, by Business Segment, 2021
Figure 79: F. Hoffmann-La Roche Ltd., Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2021
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Blood Transfusion Diagnostics Market
*Mail attachment includes 79 figures & 30 tables